Zynerba Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
July 20, 2018 at 22:19 PM EDT
Zynerba Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 4,062,500 shares of its common stock at a price of $8.00 per share, for a gross deal size of $32.5 million. Stock is down 24% as a result.